| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,501 |
14,249 |
$951K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
5,159 |
5,144 |
$333K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,385 |
1,292 |
$89K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,371 |
4,084 |
$88K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
961 |
957 |
$50K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,476 |
1,279 |
$21K |
| 99000 |
|
5,773 |
5,302 |
$16K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,668 |
1,631 |
$14K |
| 99441 |
|
282 |
274 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,141 |
1,059 |
$7K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
53 |
53 |
$4K |
| 81002 |
|
784 |
757 |
$1K |
| 87807 |
|
293 |
290 |
$976.50 |
| 99442 |
|
25 |
24 |
$319.80 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
202 |
185 |
$180.72 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
263 |
245 |
$128.17 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
12 |
12 |
$6.30 |
| 99072 |
|
460 |
430 |
$0.00 |
| S9083 |
Global fee urgent care centers |
21 |
18 |
$0.00 |